Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.3800
+0.0300 (1.28%)
NASDAQ· Last Trade: Aug 21st, 10:31 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors